Healthy high growth potential

Results

1541

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1541 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
MONOLITH
₹950.252.4%137.6%₹20.7b₹1,060.0072.035.6%n/aMaterials
6223
NT$6,440.005.6%413.1%NT$631.0bNT$8,430.00137.860.1%0.3%Semiconductors
501423
₹3,367.706.6%83.8%₹154.9b₹3,916.6787.637.3%0.09%Capital Goods
TMGH
ج.م97.88-1.1%75.3%ج.م201.7bج.م141.9013.135.9%0.3%Real Estate Management and Development
ADMR
Rp1,680.003.7%66.3%Rp68.7tRp2,344.8613.126.8%2.8%Materials
A458870
₩23,950.004.1%112.6%₩911.5b₩62,666.6730.040.0%n/aHealthcare
SAATVIKGL
₹427.400.9%n/a₹54.3b₹542.5022.164.0%n/aSemiconductors
FWRY
ج.م19.31-0.4%45.3%ج.م65.8bج.م22.4524.727.3%n/aDiversified Financials
GOLDR
NOK 7.61-2.4%n/aNOK 436.2mn/a19.886.0%n/aMaterials
CDR
zł263.102.3%3.2%zł26.3bzł234.5150.939.0%0.4%Media
AGP
€7.262.4%-11.5%€132.4m€8.5726.639.1%n/aCapital Goods
WAYS
SEK 39.401.3%0%SEK 345.5mSEK 58.00209.778.5%0%Tech
RHM
€1,202.005.2%-27.1%€56.1b€1,679.3846.430.5%1.0%Capital Goods
AAZ
UK£4.08-1.2%150.8%UK£465.9mUK£5.6835.725.9%0.7%Materials
MDGL
US$507.56-1.5%29.7%US$11.7bUS$678.069.163.7%n/aPharmaceuticals & Biotech
LPK
€15.05-3.5%87.4%€368.0m€22.753.7116.6%0%Tech
2368
NT$1,015.009.6%112.1%NT$519.6bNT$1,554.4436.042.6%1.0%Tech
509496
₹1,299.152.5%66.2%₹223.2b₹1,579.7537.128.9%0.2%Capital Goods
4417
JP¥4,520.00-2.4%38.9%JP¥71.4bJP¥5,800.0042.226.4%1.1%Software
9218
JP¥761.001.1%-10.0%JP¥7.9bn/a33.628.9%1.3%Healthcare
7685
JP¥3,405.007.8%98.8%JP¥195.7bJP¥4,866.6728.627.0%0.6%Retail
541967
₹773.05-0.8%179.2%₹119.7b₹915.3335.727.7%0%Consumer Durables
2455
NT$417.008.5%180.8%NT$70.2bNT$400.00101.144.7%0.6%Semiconductors
7769
NT$6,760.007.6%319.9%NT$1.2tNT$9,210.1869.847.9%1.0%Semiconductors
Page 1 of 43
Healthy high growth potential - Investing Ideas - Simply Wall St